Condition
Malignant Mesothelioma
Estimated Enrollment: 33
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 05-10 ICORG|ICORG-05-10|EUDRACT-2005-004420-39|EU-20748
Study First Received: August 8, 2007
Last Updated: December 30, 2014
Estimated Primary Completion Date: December 2009
Primary Outcome Measures:
Objective tumor response rate (complete response or partial response) as assessed by modified RECIST criteria|Time to disease progression|Overall survival|Safety|Quality of life
Sponsors and Collaborators:
Cancer Trials Ireland
Website Link: https://ClinicalTrials.gov/show/NCT00513877
